Viewing Study NCT01869933


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2026-02-11 @ 8:38 PM
Study NCT ID: NCT01869933
Status: COMPLETED
Last Update Posted: 2016-01-22
First Post: 2013-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X
Sponsor: OcuCure Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Proliferative Diabetic Retinopathy (PDR) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Proliferative, Diabetic, Retinopathy View